KAZAKHSTAN:in prospect April 2011

Kazakhstan is situated in central Asia, northwest of China; with a small portion west of the Ural River in the easternmost part of Europe. It is the world’s largest landlocked country. It is also the ninth largest country in the world.

The main activities of the Ministry of Health consist of implementing the national programme of health sector reform and development for 2005–2010 with the focus on:

1. reforms and development of the health delivery system (primary health care, sanitary epidemiological services, and health promotion);

2. improvement of the health management system;

3. maternal and child health;

4. training and re-training of health personnel (reform of medical and pharmaceutical education); and

5. the government programme “100 schools, 100 hospitals”, supervising the construction and launch of 100 hospitals in regions with high demand in new health facilities.

The Ministry of Health is also partly responsible for the construction of new pharmaceutical factories, which should cover the national demand for drugs in the framework of the newly launched government programme “30 manufacturing leaders of Kazakhstan”. Both programmes are coordinated and funded by the Fund for Sustainable Development “Samruk-Kazyna”.

The Ministry of Health reorganized the structure of its departments and committees twice during 2008–2009.

Kazakhstan faces high maternal, infant and under-5 mortality rates, high morbidity from diseases of the cardiovascular system and mental health, unhealthy lifestyles and in particular drug abuse and tobacco/alcohol use, high morbidity from communicable diseases (such as tuberculosis, HIV/AIDS and sexually transmitted diseases), nosocomial infections (such as hepatitis and HIV/AIDS through unsafe blood transfusion). Other characteristics are poor access to essential services, especially in rural places and through the old managerial capacity of health service delivery institutions, and rather high

alcohol and tobacco use and suicide rates. Additionally, Kazakhstan is facing a number of environmental challenges, including industrial pollution, land degradation, desertification, the nuclear heritage of the Semipalatinsk polygon and the negative influence of urbanization on public heath. Such zoonotic diseases as Crimean-Congo hemorrhagic fever, anthrax, brucellosis, plague and tularemia are still endemic in the country.

Maternal and infant mortality remain high and the Ministry of Health has declared its decrease to be its number one priority. Analysis shows that over half of infant mortality and a third of maternal mortality are the result of poor quality maternal and child health services and can be averted. Too much emphasis has been placed on high technology projects and activities, with heavy investments in new equipment and infrastructure over the last few years. Relatively little attention is paid to the quality of maternal and child health services and the strengthening of basic public health measures. The infant mortality rate was 14.43 per 1000 live births in 2007 which is high compared with regional data. Maternal mortality levels remain much higher than the European averages, being registered in 2007 is 47.52 per 100 000 live births.

Child immunization levels have been consistently high in Kazakhstan for all vaccine-preventable diseases. In 2008, 100% and in 2009, 99.3% of children were immunized against measles. Sexually transmitted infections sharply increased after independence, with syphilis incidence in 2007 reaching 45.9 per 100 000 population. The incidence of tuberculosis is 160.01 per 100 000 population.

Kazakhstan Pharmaceutical Market

Kazakhstan:in prospect is available at Euros 160.00

The access to the pharmaceutical marketplace of any region is always paired with risks, challenges and political, financial and economical factors specific to each region.

To know more about our report or to discuss this topic further please do not hesitate to contact us Tel/Fax: +38 044 206 17 17/18 e-mail: office@smd.net.ua

Kazakhstan:in prospect

Kazakhstan:in prospect © 2011 SMD

All information contained in this publication is copyrighted in the name of SMD (Support in Market Development), and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher.

DISCLAIMER All information contained in this publication has been researched and compiled from sources believed to be accurate and reliable at the time of publishing. However, SMD accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the publication. All information is provided without warranty, and SMD makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained.

EECCA: Region Features Economic Development Pharmaceutical Market: Executive Summary Pharmaceutical Market: Main Features Pharmaceutical Market: Structure

Kazakhstan Country profile Investment climate Healthcare system features Healthcare system funding

Kazakhstan: Pharma Market Key data Main features Guaranteed Volume of free Medical Aid (GFMA) structure Hospitals supply through the national distributor Retail market and state procurement ATC 1 dynamics. Retail total, USD ATC 1 dynamics. Retail total, Units ATC 1 dynamics. Rx segment, USD ATC 1 dynamics. Rx segment, Units ATC 1 dynamics. OTC segment, USD ATC 1 dynamics. OTC segment, Units Leading corporations. Retail total, USD Leading corporations. Retail total, Units Leading corporations. Rx segment, USD Leading corporations. Rx segment, Units Leading corporations. OTC segment, USD Leading corporations. OTC segment, Units Leading local manufacturers. Retail total, USD Leading local manufacturers. Retail total, Units Import by countries of origin

Kazakhstan: Forecast for 2011-2013 Retail Segment, USD

Addendum 2-phased opened tender procedures. 1st phase 2-phased opened tender procedures. 2nd phase

Kazakhstan:in prospect April 2011

SMD (Support in Market Development) - is a leading provider of market research, sales management and forecasting services to the pharmaceutical industry. Researches of: · Pharmaceutics establishments' purchase and sale audit · Hospital establishments' purchase audit · Second distribution audit · Import medicine analyses · Doctor prescription analyses · Ad Hoc research · Analytical services

Ukraine, 03680 Bojenko str., 86i, Kiev

Tel/Fax: +38 044 206 17 17/18 e-mail: office@smd.net.ua http://www.smd.net.ua